Revolutionising Healthcare Cystic fibrosis (CF) is a genetic disease that affects around 11,000 people in the UK, and over 160,000 globally. One of the most important bugs that causes this is Pseudomonas aeruginosa – a bacterium that is present everywhere but rarely...
Target Product Profiles for Diagnostics The Cystic Fibrosis (CF) Antimicrobial Resistance (AMR) Syndicate recently launched their diagnostic target product profiles (TPPs) detailing key characteristics of new tests needed to detect and manage lung infections in CF. A...
Combating antibiotic resistance Antibiotics are used to treat or prevent some types of bacterial infection. They are becoming less effective due to overuse in recent years. NBIC Research Fellow, Dr Callum Highmore, and researchers at the NIHR Southampton Biomedical...
Coccus Pocus 2023 Winning Stories In autumn 2023, the University of Hull launched their annual scary story competition for Halloween: Coccus Pocus! The event was organised for a fifth time, following four successful runs. We supported the competition as part of our...
Research in Focus: Labelling the Extracellular Matrix As part of #BiofilmWeek, we’re highlighting interesting and exciting biofilm research from across our network and partner research institutions. We interviewed Dr Susanne Löffler and Smilla Huzell from Ebba...
